Profile | GDS5420 / 204170_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 3608.37 | 96 |
GSM1296119 | B_lesional_pre-dose | 2831.8 | 93 |
GSM1296076 | C_lesional_pre-dose | 2277.89 | 90 |
GSM1296092 | D_lesional_pre-dose | 3358.8 | 94 |
GSM1296103 | E_lesional_pre-dose | 4161.3 | 96 |
GSM1296078 | F_lesional_pre-dose | 2580.13 | 91 |
GSM1296107 | G_lesional_pre-dose | 2433.18 | 91 |
GSM1296109 | H_lesional_pre-dose | 3355.73 | 95 |
GSM1296080 | I_lesional_pre-dose | 2301.14 | 90 |
GSM1296090 | J_lesional_pre-dose | 2336.47 | 90 |
GSM1296074 | K_lesional_pre-dose | 2899.89 | 92 |
GSM1296111 | L_lesional_pre-dose | 2684.3 | 93 |
GSM1296099 | M_lesional_pre-dose | 4669.61 | 97 |
GSM1296086 | O_lesional_pre-dose | 2525.17 | 91 |
GSM1296117 | P_lesional_pre-dose | 3647.69 | 96 |
GSM1296113 | Q_lesional_pre-dose | 2667.68 | 93 |
GSM1296096 | R_lesional_pre-dose | 4161.46 | 96 |
GSM1296105 | S_lesional_pre-dose | 1882.02 | 89 |
GSM1296098 | T_lesional_pre-dose | 3806.9 | 96 |
GSM1296101 | U_lesional_pre-dose | 3954.78 | 96 |
GSM1296121 | V_lesional_pre-dose | 2969.1 | 93 |
GSM1296088 | W_lesional_pre-dose | 2922.17 | 93 |
GSM1296082 | X_lesional_pre-dose | 2741.28 | 92 |
GSM1296115 | Y_lesional_pre-dose | 3239.54 | 94 |
GSM1296084 | Z_lesional_pre-dose | 2857.92 | 93 |
GSM1296072 | B_lesional_day8 | 955.06 | 78 |
GSM1296069 | L_lesional_day8 | 1776.02 | 88 |
GSM1296071 | P_lesional_day8 | 1419.13 | 85 |
GSM1296070 | Y_lesional_day8 | 1863.58 | 89 |
GSM1296073 | V_lesional_day8 | 4173.34 | 96 |
GSM1296034 | A_lesional_day15 | 728.41 | 73 |
GSM1296041 | G_lesional_day15 | 2046.84 | 89 |
GSM1296035 | R_lesional_day15 | 3753.85 | 96 |
GSM1296038 | U_lesional_day15 | 3242.06 | 94 |
GSM1296047 | B_lesional_day15 | 844.56 | 76 |
GSM1296039 | E_lesional_day15 | 4405.41 | 96 |
GSM1296042 | H_lesional_day15 | 1431.55 | 85 |
GSM1296043 | L_lesional_day15 | 1742.95 | 88 |
GSM1296037 | M_lesional_day15 | 1079.65 | 81 |
GSM1296046 | P_lesional_day15 | 774.77 | 75 |
GSM1296044 | Q_lesional_day15 | 1459.13 | 86 |
GSM1296045 | Y_lesional_day15 | 1311.81 | 84 |
GSM1296025 | C_lesional_day15 | 711.24 | 73 |
GSM1296033 | D_lesional_day15 | 1141.95 | 81 |
GSM1296027 | I_lesional_day15 | 502.67 | 68 |
GSM1296032 | J_lesional_day15 | 527.1 | 68 |
GSM1296024 | K_lesional_day15 | 611.45 | 71 |
GSM1296031 | W_lesional_day15 | 982.66 | 79 |
GSM1296028 | X_lesional_day15 | 932.02 | 78 |
GSM1296029 | Z_lesional_day15 | 1318.44 | 83 |
GSM1296026 | F_lesional_day15 | 1796.49 | 87 |
GSM1296030 | O_lesional_day15 | 2184.07 | 90 |
GSM1296040 | S_lesional_day15 | 3094.2 | 94 |
GSM1296036 | T_lesional_day15 | 3429.54 | 95 |
GSM1296048 | V_lesional_day15 | 2528.18 | 92 |
GSM1296059 | A_lesional_day43 | 3033.77 | 94 |
GSM1296066 | G_lesional_day43 | 1992.25 | 89 |
GSM1296060 | R_lesional_day43 | 3387.67 | 95 |
GSM1296063 | U_lesional_day43 | 2880.29 | 93 |
GSM1296064 | E_lesional_day43 | 3583.66 | 94 |
GSM1296067 | H_lesional_day43 | 1165.22 | 82 |
GSM1296062 | M_lesional_day43 | 3375.02 | 95 |
GSM1296068 | Q_lesional_day43 | 971.83 | 79 |
GSM1296050 | C_lesional_day43 | 616.59 | 71 |
GSM1296057 | D_lesional_day43 | 1486.93 | 85 |
GSM1296052 | I_lesional_day43 | 454.74 | 66 |
GSM1296054 | J_lesional_day43 | 414.16 | 64 |
GSM1296049 | K_lesional_day43 | 747.03 | 74 |
GSM1296055 | W_lesional_day43 | 1067.4 | 80 |
GSM1296053 | X_lesional_day43 | 822.49 | 76 |
GSM1296058 | Z_lesional_day43 | 1360.72 | 84 |
GSM1296051 | F_lesional_day43 | 2091.45 | 89 |
GSM1296056 | O_lesional_day43 | 3304.75 | 94 |
GSM1296065 | S_lesional_day43 | 1752.85 | 88 |
GSM1296061 | T_lesional_day43 | 3204.13 | 95 |
GSM1296095 | A_non-lesional_pre-dose | 2732.39 | 92 |
GSM1296120 | B_non-lesional_pre-dose | 1117.14 | 81 |
GSM1296077 | C_non-lesional_pre-dose | 904.95 | 77 |
GSM1296093 | D_non-lesional_pre-dose | 731.84 | 74 |
GSM1296104 | E_non-lesional_pre-dose | 1820.72 | 88 |
GSM1296079 | F_non-lesional_pre-dose | 506.88 | 68 |
GSM1296108 | G_non-lesional_pre-dose | 916.79 | 78 |
GSM1296110 | H_non-lesional_pre-dose | 1065.58 | 81 |
GSM1296081 | I_non-lesional_pre-dose | 378.94 | 63 |
GSM1296091 | J_non-lesional_pre-dose | 959.56 | 78 |
GSM1296075 | K_non-lesional_pre-dose | 1185.14 | 81 |
GSM1296112 | L_non-lesional_pre-dose | 867.49 | 77 |
GSM1296100 | M_non-lesional_pre-dose | 777.6 | 75 |
GSM1296087 | O_non-lesional_pre-dose | 954.19 | 78 |
GSM1296118 | P_non-lesional_pre-dose | 667.66 | 72 |
GSM1296114 | Q_non-lesional_pre-dose | 1318.86 | 84 |
GSM1296097 | R_non-lesional_pre-dose | 1891.38 | 88 |
GSM1296106 | S_non-lesional_pre-dose | 1156.75 | 81 |
GSM1296102 | U_non-lesional_pre-dose | 1993.75 | 90 |
GSM1296122 | V_non-lesional_pre-dose | 946.8 | 78 |
GSM1296089 | W_non-lesional_pre-dose | 839.34 | 76 |
GSM1296083 | X_non-lesional_pre-dose | 484.92 | 67 |
GSM1296116 | Y_non-lesional_pre-dose | 1307.17 | 84 |
GSM1296085 | Z_non-lesional_pre-dose | 838.81 | 76 |